81 related articles for article (PubMed ID: 9855329)
21. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
[TBL] [Abstract][Full Text] [Related]
22. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
23. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
Si Q; Cosenza M; Zhao ML; Goldstein H; Lee SC
Glia; 2002 Aug; 39(2):174-83. PubMed ID: 12112368
[TBL] [Abstract][Full Text] [Related]
24. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.
Angel JB
AIDS Read; 2001 Apr; 11(4):209-21. PubMed ID: 11392678
[TBL] [Abstract][Full Text] [Related]
25. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
von Mehren M; Arlen P; Gulley J; Rogatko A; Cooper HS; Meropol NJ; Alpaugh RK; Davey M; McLaughlin S; Beard MT; Tsang KY; Schlom J; Weiner LM
Clin Cancer Res; 2001 May; 7(5):1181-91. PubMed ID: 11350882
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García M; Fernández González F
Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
[No Abstract] [Full Text] [Related]
27. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
[TBL] [Abstract][Full Text] [Related]
28. The use of GM-CSF in AIDS.
Scadden DT
Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
[TBL] [Abstract][Full Text] [Related]
29. The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.
de Silva TI; Cope A; Goepel J; Greig JM
J Infect; 2007 Apr; 54(4):e207-10. PubMed ID: 17197031
[TBL] [Abstract][Full Text] [Related]
30. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
31. A view of the future: Dr. Mark Gilbert of Immunex talks about immune based therapy. Interview by Robert Nielsen.
Gilbert M
STEP Perspect; 1998; 98(1):15-7. PubMed ID: 11365210
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
Hübel K; Dale DC; Liles WC
J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
[TBL] [Abstract][Full Text] [Related]
33. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
34. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.
Daud AI; Mirza N; Lenox B; Andrews S; Urbas P; Gao GX; Lee JH; Sondak VK; Riker AI; Deconti RC; Gabrilovich D
J Clin Oncol; 2008 Jul; 26(19):3235-41. PubMed ID: 18591558
[TBL] [Abstract][Full Text] [Related]
36. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction.
Deng Z; Yang C; Deng H; Yang A; Geng T; Chen X; Ma A; Liu Z
Int J Cardiol; 2006 Oct; 113(1):92-6. PubMed ID: 16891014
[TBL] [Abstract][Full Text] [Related]
37. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
38. Study of GM-CSF enrolling.
Proj Inf Perspect; 1997 Jul; (22):14. PubMed ID: 11364571
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo.
Kedzierska K; Mak J; Mijch A; Cooke I; Rainbird M; Roberts S; Paukovics G; Jolley D; Lopez A; Crowe SM
J Infect Dis; 2000 Jan; 181(1):390-4. PubMed ID: 10608795
[TBL] [Abstract][Full Text] [Related]
40. [Oral and esophageal aphthous ulcers in a child with AIDS successfully treated with colony stimulating factors (GM-CSF)].
Pocheville I; Gutiérrez C; González J
Enferm Infecc Microbiol Clin; 1997 Oct; 15(8):439-40. PubMed ID: 9424132
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
